JP2008527988A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008527988A5 JP2008527988A5 JP2007551749A JP2007551749A JP2008527988A5 JP 2008527988 A5 JP2008527988 A5 JP 2008527988A5 JP 2007551749 A JP2007551749 A JP 2007551749A JP 2007551749 A JP2007551749 A JP 2007551749A JP 2008527988 A5 JP2008527988 A5 JP 2008527988A5
- Authority
- JP
- Japan
- Prior art keywords
- growth factor
- bacterium
- protein
- csf
- cytokines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0501540.9 | 2005-01-25 | ||
| GBGB0501540.9A GB0501540D0 (en) | 2005-01-25 | 2005-01-25 | Controlled production and delivery of biologically active agents by gut bacteria |
| PCT/GB2006/000222 WO2006079790A2 (en) | 2005-01-25 | 2006-01-24 | Controlled production and delivery of biologically active agents by gut bacteria |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008527988A JP2008527988A (ja) | 2008-07-31 |
| JP2008527988A5 true JP2008527988A5 (https=) | 2012-05-10 |
| JP4989490B2 JP4989490B2 (ja) | 2012-08-01 |
Family
ID=34259652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007551749A Expired - Fee Related JP4989490B2 (ja) | 2005-01-25 | 2006-01-24 | 腸内細菌による生物活性物質の制御された産生および送達 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7988961B2 (https=) |
| EP (1) | EP1841875B1 (https=) |
| JP (1) | JP4989490B2 (https=) |
| KR (1) | KR101291960B1 (https=) |
| AT (1) | ATE483811T1 (https=) |
| CA (1) | CA2640343C (https=) |
| DE (1) | DE602006017331D1 (https=) |
| ES (1) | ES2353721T3 (https=) |
| GB (1) | GB0501540D0 (https=) |
| WO (1) | WO2006079790A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2211879B1 (en) * | 2007-10-26 | 2014-05-07 | Brenda E. Moore | Probiotic compositions and methods for inducing and supporting weight loss |
| EP2258844A1 (en) | 2009-05-28 | 2010-12-08 | Helmholtz Zentrum Für Infektionsforschung | Tumour-specific bacterial promoter elements |
| CN102462837B (zh) * | 2010-11-19 | 2016-08-03 | 生物林格斯Ip有限公司 | 抗炎组合物 |
| WO2015095796A1 (en) | 2013-12-20 | 2015-06-25 | President And Fellows Of Harvard College | An engineered genetic enteric sensor bacteria and uses thereof |
| US9688967B2 (en) | 2014-12-05 | 2017-06-27 | Synlogic, Inc. | Bacteria engineered to treat diseases associated with hyperammonemia |
| AU2015369627A1 (en) * | 2014-12-22 | 2017-07-06 | Massachusetts Institute Of Technology | Probiotic organisms for diagnosis, monitoring, and treatment of inflammatory bowel disease |
| US20160206666A1 (en) | 2014-12-22 | 2016-07-21 | Synlogic, Inc. | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier |
| JP7095993B2 (ja) * | 2015-03-02 | 2022-07-05 | シンロジック オペレーティング カンパニー インコーポレイテッド | 消化管炎症低下および／または消化管粘膜バリア強化の利益を享受する疾患処置のために操作された細菌 |
| ES2881384T3 (es) | 2015-05-13 | 2021-11-29 | Synlogic Operating Co Inc | Bacterias manipuladas para reducir la hiperfenilalaninemia |
| US11685925B2 (en) | 2015-10-30 | 2023-06-27 | Synlogic Operating Company, Inc. | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier |
| ES2925049T3 (es) | 2015-11-16 | 2022-10-13 | Synlogic Operating Co Inc | Bacterias manipuladas para reducir la hiperfenilalaninemia |
| EP4302824A3 (en) * | 2016-04-20 | 2024-03-20 | The Board of Trustees of the Leland Stanford Junior University | Compositions and methods for nucleic acid expression and protein secretion in bacteroides |
| US11566238B2 (en) | 2016-12-15 | 2023-01-31 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for modulating growth of a genetically modified gut bacterial cell |
| US11224624B2 (en) * | 2017-02-14 | 2022-01-18 | California Institute Of Technology | Modulation of microbial synthesis of 4-etylphenol and 4-ethylphenyl sulfate in behavior and disease |
| US20200268813A1 (en) * | 2017-02-15 | 2020-08-27 | President And Fellows Of Harvard College | Modulation of host immune cell populations using gut microbiota |
| US11384358B2 (en) | 2017-03-29 | 2022-07-12 | President And Fellows Of Harvard College | Method of regulating gene expression in a cell |
| US20200056145A1 (en) * | 2017-04-17 | 2020-02-20 | The Regents Of The University Of California | Engineered commensal bacteria and methods of use |
| CN111655841A (zh) | 2017-06-21 | 2020-09-11 | 同生运营公司 | 用于治疗紊乱的细菌 |
| US12421518B2 (en) | 2018-12-10 | 2025-09-23 | Tenza, Inc. | Methods and compositions for treating hyperoxaluria |
| BR112022018571A2 (pt) | 2020-03-20 | 2022-11-01 | Synlogic Operating Co Inc | Microrganismos manipulados para reduzir a hiperfenilalaninemia |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0569604A1 (en) * | 1992-04-07 | 1993-11-18 | Societe Des Produits Nestle S.A. | Integrative gene-expression in Streptococcus salivarius ssp.thermophilus |
| GB2369618B (en) * | 1999-09-10 | 2004-06-02 | Secr Defence | Live vaccine expressing antigens using phoP or pagC promoters |
| JP2001275680A (ja) * | 2000-03-31 | 2001-10-09 | Yakult Honsha Co Ltd | β−１，３−キシラナーゼ遺伝子、該遺伝子を導入した微生物、及びβ−１，３−キシラナーゼの製造法 |
| JP2003144200A (ja) * | 2001-11-07 | 2003-05-20 | Yakult Honsha Co Ltd | バクテロイデスグループ細菌用プローブおよびこれを用いた検出方法 |
-
2005
- 2005-01-25 GB GBGB0501540.9A patent/GB0501540D0/en not_active Ceased
-
2006
- 2006-01-24 AT AT06701043T patent/ATE483811T1/de not_active IP Right Cessation
- 2006-01-24 US US11/814,739 patent/US7988961B2/en not_active Expired - Fee Related
- 2006-01-24 DE DE602006017331T patent/DE602006017331D1/de not_active Expired - Lifetime
- 2006-01-24 KR KR1020077019503A patent/KR101291960B1/ko not_active Expired - Fee Related
- 2006-01-24 JP JP2007551749A patent/JP4989490B2/ja not_active Expired - Fee Related
- 2006-01-24 CA CA2640343A patent/CA2640343C/en not_active Expired - Fee Related
- 2006-01-24 ES ES06701043T patent/ES2353721T3/es not_active Expired - Lifetime
- 2006-01-24 EP EP06701043A patent/EP1841875B1/en not_active Expired - Lifetime
- 2006-01-24 WO PCT/GB2006/000222 patent/WO2006079790A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008527988A5 (https=) | ||
| CN1195860C (zh) | 生物学活性多肽的输送 | |
| KR101291960B1 (ko) | 장내세균에 의한 생물학적 활성제의 제어된 생산 및 전달 | |
| Lillehoj et al. | Resistance to intestinal coccidiosis following DNA immunization with the cloned 3-1E Eimeria gene plus IL-2, IL-15, and IFN-γ | |
| Fraser et al. | Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines | |
| Qiao et al. | Recombinant lactic acid bacteria as promising vectors for mucosal vaccination | |
| Lowenthal et al. | Avian cytokines—the natural approach to therapeutics | |
| Vallittu et al. | Clinical guide to principles of fiber-reinforced composites in dentistry | |
| BRPI0806578A2 (pt) | Promotores de lactococcus e usos dos mesmos | |
| CN102380091A (zh) | 白介素-22在治疗病毒性肝炎中的应用 | |
| Scuderi et al. | IL-6-deficient mice show impaired inflammatory response in a model of myosin-induced experimental myositis | |
| US20210338741A1 (en) | Tissue healing agent | |
| Collins et al. | Cloning and expression of bovine and porcine interleukin-2 in baculovirus and analysis of species cross-reactivity | |
| JP2023554674A5 (https=) | ||
| US20050025806A1 (en) | Sustained release pharmaceutical composition | |
| Jenkins et al. | Effectiveness and durability of common weight loss methods | |
| CN103702680A (zh) | 采用快速滴定递增剂量方案用于降低与肌肉内施用干扰素有关的流感样症状的方法 | |
| Park et al. | Immunomodulatory effects of mixed Weissella cibaria JW15 with water extract of black soybean and burdock on Listeria monocytogenes infection in mice. | |
| Zarkovic Gjurin et al. | Zirconia ceramic fixed partial dentures after cyclic fatigue tests and clinical evaluation: a systematic review | |
| WO2023185443A1 (zh) | 智能可控的微生物药物工厂及其在皮肤伤口愈合中的应用 | |
| WO2023185442A1 (zh) | 葡萄糖调控基因表达环路控制系统及其调控血糖的应用 | |
| Thomas et al. | Expression, purification and characterisation of recombinant Escherichia coli derived chicken interleukin-12 | |
| Dunham et al. | Isolation, expression and bioactivity of feline granulocyte–macrophage colony-stimulating factor | |
| RU98109522A (ru) | Доставка биологически активных полипептидов | |
| Kim et al. | Co‐administration of live attenuated Salmonella enterica serovar Typhimurium expressing swine interleukin‐18 and interferon‐α provides enhanced Th1‐biased protective immunity against inactivated vaccine of pseudorabies virus |